Full-Service Law Firm solving complex challenges through bold thinking, precise execution, and shared purpose.

Full Service Law Firm | Michael Best & Friedrich LLP

Specializing in the Intersection of Business &amp; Government

Meet our team of trusted advisors, strategic thinkers, and community builders dedicated to client success.

Learn about our full-service legal and business solutions, designed to address complex challenges for leading organizations across industries.

Access thought leadership, news, and resources to stay informed about the latest trends, legal developments, and industry innovations.

Discover how partnership, bold thinking, and precise execution drive results for clients nationwide.

Explore how our national reach and local expertise support clients across the United States and beyond.

Grow at a firm designed to bring out your best.

Michael Best represented ReSync Bio in their recent transaction with Benchling, a cloud-based software platform powering the biotechnology industry. ReSync Bio developed software to accelerate drug discovery. Working in small molecule discovery, ReSync’s platform helped scientists run the latest scientific AI models without building their own compute infrastructure. This transaction will help make AI a part of everyday scientific research.

core/paragraph

The Michael Best team was led by Brett Valentyn, in conjunction with Shawn Stigler, as well as Elaina Bailey, Justin Mertz, Carley Peterson, Jeff Peterson, and Duncan Williams.

Learn more about Michael Best’s <a href="https://www.michaelbest.com/Practices/Corporate/Mergers-Acquisitions">M&amp;A team and capabilities here</a>.

Two people reviewing information on a tablet with printed financial documents on a desk.

Blurred close-up of business documents with blue charts and a pen resting on top.

Michael Best Represents ReSync Bio in Strategic Transaction

Related People

Related Capabilities

You may also be interested in these

Michael Best Welcomes Dana Bell as Senior Counsel in Intellectual Property Practice

Copyright or Trade Secret? How Software Companies Should Decide What to Protect—and How

Seventh Circuit Grapples with BIPA Amendment.